The digital therapeutics developer received authorization for a Type 2 diabetes treatment app last year but has struggled for money.
Better Therapeutics lays off staff, considers winding down business Read More »
Inspectors found fault with the handling of corrective and preventive actions for the Ivenix Infusion System.
Fresenius Kabi receives FDA warning letter over issues at ex-Ivenix site Read More »
The president of Medtronic’s cardiovascular portfolio talked about renal denervation, a new procedure to reduce blood pressure, and rising competition in cardiac ablation.
Medtronic’s Sean Salmon on cardiovascular competition, carving out new markets Read More »
The appointment will help fill out the North Carolina-based health system’s leadership team after its CFO and COO left last year.
El estudio tesina realizado por Víctor Fernández Massó para el experto en psicologia social de la Universidad de San Jorge en Zaragoza con la colaboración del abogado Luis Soto Tejedor SG LEGAL CONSULTING, del Ilustre Colegio de Abogados de Barcelona aborda de manera profunda las implicacion …
Explorando las implicaciones del aislamiento: Un estudio profundo Read More »
Madrigal Pharmaceuticals’ Rezdiffra is the first FDA-approved treatment for noncirrhotic non-alcoholic steatohepatitis, now referred to as metabolic dysfunction-associated steatohepatitis.
NASH or MASH: No Matter What You Call It, Madrigal’s FDA Approval Is a Big Deal Read More »
The cloud-based software company announced a number of new AI tools in the lead up to the HIMSS conference. Healthcare is a “huge priority” for Salesforce, said Sean Kennedy, global health strategy lead.
The FDA approved Bristol Myers Squibb’s Breyanzi for chronic lymphocytic leukemia and small lymphocytic leukemia prior to Friday’s adcomm for the company’s other CAR-T therapy, Abecma.
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia Read More »
Si estás considerando adquirir un vehículo eléctrico o ya eres propietario de uno y quieres saber cuál es el mejor cargador doméstico para tu modelo, no está de más que conozcas cuáles son los distintos modos de recarga. As&i …
Cuál es el mejor cargador para coches eléctricos Read More »
Merck, known as MSD outside of the United States and Canada, announced that the Phase 3 KEYNOTE-A18 trial, also known as ENGOT-cx11/GOG-3047, investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemoradiotherapy met its primary endpoint of overall survival for the treatment of newly diagnosed patients with high-risk locally advanced cervical cancer.
